The article Posted on March 30, 2017 by the American College of Radiology begins: A recent analysis of newly added 2014 data to the National Cancer Institute SEER database by R. Edward Hendrick, PhD, shows that the breast cancer death rate has now fallen 38 percent since 1990. Read more...
Recent News and Views
Breast Cancer Deaths Continue Yearly Decline
3 Apr 2017
Today Show Episode with Joan Lunden and Dr. Calamari
19 Oct 2016
Watch the Today Show episode with Joan Lunden speaking with Dr. Calamari about mammography and the importance of knowing if you have dense breasts: Read more...
CDC report on screening
According to a recent report by the Center for Disease Control and Prevention (CDC) the number of Americans being screened for breast, colon and cervical cancers is below the targets set by the U.S. Preventive Services Task Force (USPSTF). Healthy People 2020 sets national objectives for use of the recommended cancer screening tests and identifies the National Health Interview Survey (NHIS) as the means to measure progress. Data from the 2010 NHIS were analyzed to assess use of the recommended tests by age, race, ethnicity, education, length of U.S. residence, and source and financing of health care to identify groups not receiving the full benefits of screening and to target specific interventions to increase screening rates.
In 2010, 72.4 percent of women were being screened for breast cancer (below the 81.1 percent target), cervical cancer screening was 83.0 percent (below the target of 93.0 percent) and colorectal cancer screening was 58.6 percent (below the target of 70.5 percent).
The report indicates that screening rates for all three cancer screening tests were significantly lower among Asians than among whites and blacks. Hispanics were less likely to be screened for cervical and colorectal cancer. Higher screening rates were positively associated with education, availability and use of health care, and length of U.S. residence.
Recommendations made in the report include increased efforts to improve screening rates in all population groups (including targeting populations with particularly low levels of cancer screening) to increase population screening levels to meet Healthy People 2020 targets and reduce cancer morbidity and mortality.